Techno-Economic Analysis

Understand your product’s economic viability and market competitiveness like an expert

What is Techno-Economic Analysis?

Techno-economic analyses (TEAs) provide a systematic and rigorous evaluation of the economic viability of a technology. TEAs are key resources that help businesses inform decision making to maximize upside and minimize potential costs and risks.

Why Synonym’s TEA is best in the market

Comprehensive

Includes more than 70 technology, commercial and operational variables (titers, fermentation times, product pricing, facility sizes and more).

Dynamic

An integrated CapEx and OpEx model that dynamically updates as variables are adjusted for your desired scenarios.

Accurate

Captures all meaningful costs associated with first-of-a-kind projects that are often missed (cost of capital, construction indirects, project guarantees).

Scenario-Based

Considers various scenarios and sensitivities to quantify risks and uncertainties associated with your project and technology.

Resilient

Spreadsheet-based, so it’s easy to use and transferable to teammates in the case of unforeseen personnel or organization changes.

Growth-Oriented

Incorporates decreasing costs from pioneer facilities to nth facilities based on future cost savings and efficiencies.

What do you get with a Synonym TEA?

Production & Financial Model

Dynamic spreadsheet model customized to your bioprocess

Utility Summary

Sized & Priced Equipment List

Mass & Energy Balance

COGS Breakdown

CapEx Breakdown

Project Proforma

Analysis & Insights

Summary of key analyses and commentary to inform business decisions

Total Project Cost Overview

Sensitivity Analyses

Identify Key Cost Drivers

COGS Commentary

CapEx Commentary

High-Level Bankability Commentary

TEA Samples

Everyone needs
a TEA to assess
if a technology can compete
on process performance
and price

  • It’s already pretty awesome and this could really change the conversation around the biomanufacturing industry! It’s so useful to have a quick tool to put numbers around intuitions and understand what needs to change to get to target COGS.

    Friederike Grosse-Holz

    Director, Blue Horizon

  • By providing startups with a way to effectively value the feasibility of their technology and de-risk the scalability, Synonym Bio's Scaler tool is a major disrupter in the life sciences/biotech space. The result is a high-value, TEA model that effectively communicates a startup's economic viability.

    Anne Palermo

    CEO, Aqua Cultured Foods

  • Synonym's Insights helped us define our production scale-up strategy. Their COGS calculations gave us a clear view into what our price curve could look like as we scale.

    Arturo Elizondo

    CEO, The EVERY Company

  • Synonym's Insights helped us define our production scale-up strategy. Their COGS calculations gave us a clear view into what our price curve could look like as we scale.

    Arturo Elizondo

    CEO, The EVERY Company

  • By providing startups with a way to effectively value the feasibility of their technology and de-risk the scalability, Synonym Bio's Scaler tool is a major disrupter in the life sciences/biotech space. The result is a high-value, TEA model that effectively communicates a startup's economic viability.

    Anne Palermo

    CEO, Aqua Cultured Foods

  • It’s already pretty awesome and this could really change the conversation around the biomanufacturing industry! It’s so useful to have a quick tool to put numbers around intuitions and understand what needs to change to get to target COGS.

    Friederike Grosse-Holz

    Director, Blue Horizon